A5044840118- Pulmonary Hypertension Research and Treatments
- Cardiovascular Issues in Pregnancy
- Cardiovascular Function and Risk Factors
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Venous Thromboembolism Diagnosis and Management
- Vascular Anomalies and Treatments
- Cardiac Arrhythmias and Treatments
- Heart Failure Treatment and Management
- Systemic Sclerosis and Related Diseases
- Chronic Obstructive Pulmonary Disease (COPD) Research
- COVID-19 Clinical Research Studies
- Inflammasome and immune disorders
- Transplantation: Methods and Outcomes
- Cardiovascular and Diving-Related Complications
- Ovarian function and disorders
- Nephrotoxicity and Medicinal Plants
- Acute Myocardial Infarction Research
- Long-Term Effects of COVID-19
- Mycobacterium research and diagnosis
- Systemic Lupus Erythematosus Research
- Coronary Interventions and Diagnostics
- Chronic Kidney Disease and Diabetes
- Cardiac Health and Mental Health
- Heart Rate Variability and Autonomic Control
- Case Reports on Hematomas
European Hospital
2024
Institute of Plasma Physics and Laser Microfusion
2013
In-Q-Tel
2012
Instytut Gruźlicy i Chorób Płuc
2007-2010
To assess the safety and efficacy of a refined balloon pulmonary angioplasty (BPA) strategy in patients with chronic thromboembolic hypertension (CTEPH).There were 157 BPA sessions performed 56 CTEPH (47 non-operable, nine after endarterectomy; aged 58.6 ± 17.9 years; 28 females) severely impaired haemodynamics (mean artery pressure [mPAP]: 51.3 12.2 mm Hg, vascular resistance [PVR]: 10.1 3.9 Wood Units). The first 50 aimed to recanalise occlusions prevent reocclusion aggressive...
Background: Treprostinil, which is administered via continuous subcutaneous or intravenous infusion, a medication applied in the treatment of pulmonary arterial hypertension (PAH). The dose treprostinil adjusted on an individual basis for each patient. A number factors determine how well patients respond to treatment. Objectives: aim this study was identify that may influence clinical response at 3 months after start therapy. Methods: influencing were analyzed consecutive PAH who started...
Chronic thromboembolic pulmonary hypertension (CTEPH) is an ominous disease leading to progressive right heart failure. Selected patients can be treated by endarterectomy (PEA). We assessed long-term clinical outcome of with CTEPH who underwent PEA and remained on medical treatment alone. A total 112 consecutive referred between 1998 2008 one center were followed for a mean 35 (range 0-128) months after diagnosis. All the had advanced at baseline. The operated group higher World Health...
The COVID-19 pandemic has affected the physical and mental health of people around world. This may be particularly true for patients with life-threatening diseases. We analyzed level fear (FCV-19S), prevalence anxiety (HADS-A) depression (HADS-D) in pulmonary arterial chronic thromboembolic hypertension (PAH CTEPH) during pandemic. In this multicenter prospective study, 223 (63% females, 66% PAH) age range 18–90 years were included. was high, at a mean 18.9 ± 7.4 points. Anxiety (HADS-A ≥ 8...
The incidence of COVID-19 infection in patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic (CTEPH) is similar to that the general population, but mortality rate much higher. vaccination strongly recommended for PAH/CTEPH patients. aim our cross-sectional study was identify reasons why refused against COVID-19. Moreover, we assessed safety profile approved vaccines We examined 261 (164 PAH 97CTEPH patients) a median age 60 (18-92) years, 62% which were female....
Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary (CTEPH) lead to progressive right heart failure. The mortality rates in PAH CTEPH patients due COVID‑19 are high, vaccination against is recommended this group.We analyzed the incidence outcomes of COVID‑19in PAH/CTEPH for 2 years pandemic, as well predictors worse group.PAH/CTEPH patient data observational, cohort study were obtained from 3 centers between March 11, 2020 2022.A total 364 consecutive with (248/122;...
The remodeling of the right heart in patients with chronic pulmonary hypertension (cPH) is associated appearance electrocardiographic (ECG) abnormalities. We investigated resolution ECG markers ventricular hypertrophy (RVH) caused by acute and long-term hemodynamic improvement.Twenty-nine (29) thromboembolic (CTEPH) seven arterial (PAH) were included analysis. Patients CTEPH achieved a significant improvement following treatment balloon angioplasty (BPA); all PAH reported relief after single...
Right ventricular failure is a leading cause of mortality in patients with pulmonary arterial hypertension (PAH). However, up to 25% such die unexpectedly, without warning signs hemodynamical decompensation. We previously documented that artery (PA) dilatation significantly increases the risk those deaths. Some them may be due dissection PA resulting cardiac tamponade. direct confirmation this mechanism difficult as most deaths occur outside hospitals. present 4 severe PAH and whom has been...
as assessed with echocardiography. 10,11
Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary (CTEPH) patients have a more severe COVID-19 course than the general population. Many report different persistent symptoms after SARS-CoV-2 infection. The aim of our study is to analyze prevalence long assess if affects (PH) prognosis. PAH/CTEPH who survived for at least 3 months before visiting PH centers were included in study. assessed acute phase infection persisting follow-up visit, WHO functional class, 6-min...
Non-tuberculous mycobacterial lung diseases (NTMLD) occur rarely and are diagnosed mainly in patients belonging to risk groups. Pulmonary hypertension (PH) has not been recognised as a factor for NTMLD yet. The aim of the study was analyse clinical course predisposing factors our centre between 2002 2012 with chronic thromboembolic pulmonary (CTEPH) idiopathic arterial (IPAH).Thirteen (10 - CTEPH, 3 IPAH) entered study. PH during right heart catheterisation. Median value mean artery pressure...
The risk stratification in idiopathic pulmonary arterial hypertension (IPAH) patients is currently based on haemodynamic and functional parameters as well serum biomarker concentrations. Until now the importance of changes appearing high-resolution computed tomography (HRCT) lungs with IPAH has not been investigated.Lung HRCT scans were analysed retrospectively 48 (patients): 37 women, 11 men, mean age 41 +/- 15 years.Focal ground-glass opacifications (FGG) found 12 (25%), centrilobular...
Effective targeted therapy of pulmonary arterial hypertension (PAH) and chronic thromboembolic (CTEPH) requires regular risk stratification. Among many prognostic parameters, three hemodynamic indices: right atrial pressure, cardiac index, mixed venous saturation are considered critically important for correct classification. All them measured invasively require heart catheterization (RHC). The study was aimed to verify assumption that a model based on non-invasive parameters is able predict...
One of the non-pharmacological recommendations for stable patients with pulmonary arterial hypertension (PAH) is to increase physical activity. The study aimed analyze degree activity PAH and check if mental factors may have a potential negative impact during COVID-19 pandemic. Forty were included in study. Physical was assessed by pedometer (Omron HJ-321-E) four weeks. At baseline, addition 6 min walk test (6MWT) functional assessment, completed quality-of-life questionnaire SF-36, fear...
Background: There was increased risk of mental disturbances during the COVID-19 pandemic. Patients with chronic diseases, including pulmonary arterial hypertension (PAH) and thromboembolic (CTEPH), were particularly vulnerable. Our previous study showed high levels fear (FCV-19S), anxiety (HADS-A), depression (HADS-D) in second year pandemic among PAH/CTEPH patients. The aim present to assess changes FCV-19S, HADS-A, HADS-D after removing restrictions related Methods: In this prospective,...
Appropriate levels of physical activity (PhA) provide health benefits to patients with chronic diseases, including pulmonary arterial hypertension (PAH). In this study, we examined the effect physicians' PhA recommendations on PhA, and effectiveness self-monitoring using a pedometer for PAH patients.
Abstract Background Malnutrition has been demonstrated as a predictor for unfavorable clinical outcomes in chronic heart failure, and may affect patients with pulmonary arterial hypertension (PAH). The Mini Nutritional Assessment (MNA) is reliable indicator nutritional status assessment, but its relationship mortality risk hospitalization PAH not yet investigated. Purpose study aimed to determine whether the MNA prognostic value stable PAH. Methods A prospective multicenter was performed....